Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors

Xuwang Chen; Xin Liu; Qing Meng; Ding Wang; Huiqing Liu; De Clercq Erik; Christophe Pannecouque; Jan Balzarini; Xinyong Liu

doi:10.1016/j.bmcl.2013.10.059

Back

Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors

Article 2013 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2025

Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Zhenzhen Zhou, Jie Guo, Xin Li, Jinyuan Wu, De Clercq Erik, Christophe Pannecouque, Peng Zhan, Dongwei Kang, Xinyong Liu

Article2022

Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Da Feng, Hao Lin, Liyang Jiang, Zhao Wang, Yanying Sun, Zhongxia Zhou, De Clercq Erik, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu

Article2014

Structural modification of diarylpyrimidine derivatives as HIV-1 reverse transcriptase inhibitors

Shuang‐Xi Gu, Yuan‐Yuan Zhu, Fen‐Er Chen, De Clercq Erik, Jan Balzarini, Christophe Pannecouque

Article2024

Identification of novel diarylpyrimidine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against wild-type and K103N mutant viruses

Xiangyi Jiang, Waleed A. Zalloum, Zhen Gao, Jiaojiao Dai, Xiangkai Ji, Minghui Xie, Guanyu Dong, De Clercq Erik, Boshi Huang, Christophe Pannecouque, Peng Zhan, Xinyong Liu

Preprint2024

Design and Synthesis of Novel Diarylpyrimidine Derivatives as Hiv-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Potency and Metabolic Stability

Xinyong Liu, Hao Lin, Da Feng, Jie Guo, Xiangyi Jiang, Yanying Sun, Xiangkai Ji, De Clercq Erik, Christophe Pannecouque, Chin‐Ho Chen, Dongwei Kang, Peng Zhan